The central $29 target is a calculated average of verified analyst price targets, not an official published consensus. Across roughly 13 current targets tracked by S&P Global, figures span from a low of $17 (Barclays, initiated October 2026) to a high of $50 (Wedbush), with a mean near $29. The overall rating mix skews positive—roughly seven to eight Buy ratings and five Hold ratings, with no Sell ratings—but the dispersion is unusually wide, signaling genuine disagreement about the stock's fair value.
The most recent revisions have been notably cautious. Morgan Stanley cut its target to $19 from $35 (Hold) in October 2026, Goldman Sachs trimmed to $22 from $24, and Deutsche Bank lowered to $28 from $36 while keeping a Buy. In contrast, firms such as Needham ($40), Craig-Hallum ($35), Citi ($35), and Clear Street (near $50) maintain substantially higher Buy-rated targets, arguing the company's defense and intelligence backlog is underappreciated. This wide $17-to-$50 range means the average should be read as a central tendency, not a prediction. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
PL shares closed near $10.53 on November 20, 2026, down sharply from a 52-week high of $51.76. To reach $29, the stock would need to climb roughly 175% from current levels—an extraordinary move that would require a fundamental re-rating, not merely a modest recovery. Trailing revenue is about $378 million with a net loss on a GAAP basis, though the company has recently reported near-breakeven or slightly positive adjusted EPS.
The path toward $29 would likely require Planet Labs to sustain revenue growth of roughly 30% to 40%, expand margins, convert its growing defense and government pipeline into signed contracts, and persuade investors it can grow into a valuation that currently embeds little near-term profit. It would also require the stock to reclaim multiple prior support zones it has broken through on the way down.
Planet Labs trades just above its 52-week low of $10.35, which is the most important near-term support level; a decisive close below it would open the door to fresh lows. On the upside, the $17-to-$20 area marks the first meaningful resistance zone, aligning with several recently lowered analyst targets, while the stock's former highs near $50 represent a much more distant recovery objective. The overall structure remains a downtrend from the peak, meaning any sustained move toward $29 would likely require a series of higher lows and reclaimed levels rather than a single advance.
Analyst price targets generally reflect a research horizon of roughly 12 months, though individual firms rarely state a precise date. The next quarterly earnings report is a key catalyst, as are updates to revenue guidance, new defense or government contract awards, and any further analyst target revisions. Investors should also watch satellite launch progress, adoption of AI-enabled products, and the company's progress toward sustained profitability, since the gap between the $29 average target and the $10.53 market price will close only if fundamentals or sentiment improve materially. From what I see, monitoring these elements closely helps frame realistic expectations.
In my own research process, I often turn to Tickeron’s AI Daily Buy/Sell Signals to track how daily shifts in momentum and technical patterns play out for names like this. The system scans thousands of stocks and ETFs to flag Buy, Sell, or Hold signals based on changing conditions, which can be especially useful when sentiment around a volatile name moves quickly. It has become a practical way for me to stay aligned with emerging trends without replacing my own analysis.
The $29 central target is a calculated average of roughly 13 analyst price targets ranging from $17 to $50, and it sits about 175% above the current price of roughly $10.53. The strong supporting factors—defense and government demand, AI-enabled imagery, and robust expected revenue growth—are real but have not yet translated into sustained profitability or a rebound in investor sentiment. The principal obstacles are persistent GAAP losses, a badly damaged chart, and a wide divergence between the most cautious and most bullish analysts. Whether Planet Labs can reach $29 depends on execution and sentiment far more than on any single target, and investors should treat the figure as a framework for monitoring the company rather than as a forecast.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
PL saw its Momentum Indicator move below the 0 level on November 20, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 88 similar instances where the indicator turned negative. In 78 of the 88 cases, the stock moved further down in the following days. The odds of a decline are at 89%.
The Moving Average Convergence Divergence Histogram (MACD) for PL turned negative on November 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 41 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 84%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for PL entered a downward trend on November 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator entered the oversold zone -- be on the watch for PL's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +26.38% 3-day Advance, the price is estimated to grow further. Considering data from situations where PL advanced for three days, in 214 of 264 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
PL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 13 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 45 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.091) is normal, around the industry mean (5.050). P/E Ratio (-11.409) is within average values for comparable stocks, (17.247). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.110). Dividend Yield (0.000) settles around the average of (0.055) among similar stocks. P/S Ratio (14.104) is also within normal values, averaging (18.367).
The Tickeron Price Growth Rating for this company is 81 (best 1 - 100 worst), indicating slightly worse than average price growth. PL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 97 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry AerospaceDefense